SCHEMBL27178205

SCHEMBL27178205

C/C(=N\NC(=O)c1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.72
RAB9A P51151 8/20 0.72
SMN1; SMN2 Q16637 5/20 0.72
CYP1A2 P05177 3/20 0.72
CYP2C19 P33261 3/20 0.72
MEN1 O00255 3/20 0.72
KMT2A Q03164 3/20 0.72
NFKB1 P19838 2/20 0.72
NFKB2 Q00653 2/20 0.72
RELA Q04206 2/20 0.72
CYP3A4 P08684 2/20 0.72
CASP3 P42574 1/20 0.72
SENP7 Q9BQF6 1/20 0.72
SENP6 Q9GZR1 1/20 0.72
POLB P06746 3/20 0.68
CA1 P00915 2/20 0.68
CA2 P00918 2/20 0.68
CA4 P22748 2/20 0.68
CA9 Q16790 2/20 0.68
GAA P10253 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27177850 1.00 NPC1 (0.72) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19
SCHEMBL27177914 1.00 NPC1 (0.72) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19
SCHEMBL27177853 1.00 NPC1 (0.72) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19
SCHEMBL27178212 1.00 NPC1 (0.72) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19
SCHEMBL27178061 0.93 CA1 (0.75) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19
SCHEMBL27178058 0.93 CA1 (0.75) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19
SCHEMBL1563352 0.90 RAB9A (0.81) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19
SCHEMBL1563351 0.90 RAB9A (0.81) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19
SCHEMBL5732784 0.90 RAB9A (0.81) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19
SCHEMBL27532371 0.88 RAB9A (0.78) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4580403-A2 APYRASE INHIBITORS Texas Crop Science, Inc. (US) 2025-07-09 EP claimed
US-20240101510-A1 APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US claimed
WO-2024050040-A2 APYRASE INHIBITORS TEXAS CROP SCIENCE (US) 2024-03-07 WO claimed
US-20240101510-A1 APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240101510-A1 APYRASE INHIBITORS APEH, DPEP1, PON1 NPC1 2564/4885RAB9A 1387/4885SMN1; SMN2 4511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.